Skip to main content
TipRanks
Go Ultimate75% OFF

Aviva plc (GU81) Q2 2026 Earnings Report

6 Followers

DE:GU81 Q2 2026 EPS Results

Actual EPS
EUR 0.38
Consensus EPS
EUR 0.37
Beat/Miss
Beat by +EUR 0.02
One Year Ago EPS
EUR 0.35

DE:GU81 Q2 2026 Revenue Results

Actual Revenue
EUR 40.93B
Expected Revenue
EUR 34.49B
Beat/Miss
Beat by +EUR 6.44B
YoY Revenue Growth
+70.95%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/14/2026
Time
Before Open
Conference Call
Friday, August 14, 2026
DE:GU81 Upcoming Earnings

Aviva plc's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 14, 2026|% Change Since:8.31%|
Earnings Call Sentiment|Positive

The call highlighted multiple strong financial and operational outcomes — notably 24% operating profit growth, double-digit EPS growth, >20% IFRS ROE, large Wealth net flows (+32%), significant Direct Line synergies already delivered, and clear progress toward capital-lighting the business. These positives are tempered by near-term challenges including Health missing its GBP 100m target, a 14% drop in Protection profit, idiosyncratic large losses (particularly in Canada), one-off write-offs weighing on underlying COR, and elevated Q3 weather/CAT risk in Canada. On balance the positive momentum, delivered synergies, strong capital and cash generation, and scalable AI and customer advantages outweigh the setbacks, supporting an optimistic outlook for achieving the 3-year targets and sustained growth beyond 2028.

Company Guidance

Management reiterated full‑year guidance of around 11% operating EPS (slightly above prior guidance) and said the group is on track for its 2026 combined‑ratio guidance, with H1 operating profit up 24% to £1.3bn, H1 operating EPS +10%, IFRS RoE 20.3% and cash remittances +47% to £1.5bn; solvency was 176% at H1 and is expected to be in the high‑180s by year‑end (including at least 7 additional points / ~£350m of Direct Line capital synergies), with cost synergies from Direct Line of £130m this year (c.£100m run‑rate already delivered), £150m capital synergies and £40m annual claims savings announced; underlying operating capital generation rose 14% to £812m, Wealth net flows were +32% to £7.6bn (AUM >£260bn) and the business remains on track to £280m operating profit by 2027, Retirement BPA written £1.1bn (YTD £1.9bn) with an H1 IRR of 18%, Health operating profit now expected ~£90m for 2026, BAU change investment is ~£450m p.a., and the group remains confident in its 3‑year targets and in reaching ~75% capital‑light by end‑2028.

  • Strong Group ProfitabilityOperating profit up 24% to GBP 1.3bn; operating EPS growth of 10%; IFRS return on equity 20.3% (above 20%).
  • Material Cash Generation and Capital PositionCash remittances up 47% to GBP 1.5bn; solvency ratio 176% at half year and expected to be in the high 180s by year-end; underlying operating capital generation up 14% to GBP 812m.
  • Shareholder ReturnsCompleted latest share buyback; interim dividend increased to 14p per share, up 7%.
  • Direct Line Integration and SynergiesDirect Line integration progressing well: premiums nearly doubled in U.K. Personal Lines; delivered GBP 100m run-rate cost synergies, GBP 150m capital synergies and GBP 40m annual claims cost savings to date; expecting GBP 130m of cost synergies this year (to flow fully next year); written combined ratios improved by more than 10 points at Direct Line.
  • Wealth Momentum and FlowsWealth net flows up 32% to GBP 7.6bn (c.7% of opening AUM annualized); AUM > GBP 260bn; Wealth operating profit up 34%; on track for GBP 280m operating profit ambition by 2027.
  • General Insurance ImprovementGroup General Insurance undiscounted combined operating ratio improved by more than 2 points over 2 years; U.K. & Ireland combined ratio ~93.3–93.4% (improvement ~1.1–1.3 points).
  • Retirement Business PerformanceBulk purchase annuity writing GBP 1.1bn BPA in the half; achieved an IRR of 18% (above low-teens guidance); individual annuity sales up 11% to GBP 865m and operating profit up 2%.
  • Scale and Customer AdvantageMore than 25 million customers; multiproduct customers increased from 4.7m in 2022 to over 7m today; nearly half of new policies are sold to existing customers, driving lower acquisition costs and higher retention.
  • AI and Technology DeploymentSignificant AI investment within a disciplined £450m annual change budget; examples include >GBP 200m run-rate pricing benefits in U.K. Personal Lines, claims and underwriting automation (e.g., halved medical underwriting time), AI virtual assistant and agentic AI in Wealth to save 50% back-office time.
  • Capital-Light ProgressEarnings mix now ~70% capital-light (up from a 50/50 split four years ago); on track to reach 75% capital-light by end-2028, supporting faster growth and higher returns.

DE:GU81 Earnings History

DE:GU81 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.35-0.33――
Aug 14, 20262026 (Q2)0.370.380.359.66% (+0.03)
Mar 05, 20262025 (Q4)0.380.330.310.93% (+0.03)
Aug 14, 20252025 (Q2)0.320.350.2824.46% (+0.07)
Feb 27, 20252024 (Q4)0.290.300.31-3.14% (-0.01)
Aug 14, 20242024 (Q2)0.250.280.2417.09% (+0.04)
Mar 07, 20242023 (Q4)0.240.310.52-41.11% (-0.21)
Aug 16, 20232023 (Q2)0.190.240.28-15.32% (-0.04)
Mar 09, 20232022 (Q4)0.270.520.3645.30% (+0.16)
Aug 10, 20222022 (Q2)0.180.280.03840.00% (+0.25)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed